Multiple acyl-CoA dehydrogenation deficiency as decreased acyl-carnitine profile in serum
- 1 April 2015
- journal article
- research article
- Published by Springer Nature in Neurological Sciences
- Vol. 36 (6) , 853-859
Abstract
We report a case with late onset riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency (MADD) characterized by decreased acyl-carnitine profile in serum which is consistent with primary systemic carnitine deficiency (CDSP) while just the contrary to a typical MADD. This patient complained with muscle weakness, muscle pain and intermittent vomiting, and was diagnosed as polymyositis, received prednisone therapy before consulted with us. Muscle biopsy revealed mild lipid storage. The findings of serum acyl-carnitines were consistent with CDSP manifesting as decreased free and total carnitines in serum. But oral l-carnitine supplementation was not very effective to this patient and mutation analysis of the SLC22A5 gene for CDSP was normal. Later, another acyl-carnitine analysis revealed a typical MADD profile in serum, which was characterized by increased multiple acyl-carnitines. Compound heterozygous mutations were identified in electron transferring-flavoprotein dehydrogenase (ETFDH) gene which confirmed the diagnosis of MADD. After administration of riboflavin, he improved dramatically, both clinically and biochemically. Thus, late onset riboflavin-responsive MADD should be included in the differential diagnosis for adult carnitine deficiency.Keywords
This publication has 18 references indexed in Scilit:
- Increased muscle coenzyme Q10 in riboflavin responsive MADD with ETFDH gene mutations due to secondary mitochondrial proliferationMolecular Genetics and Metabolism, 2013
- Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and managementOrphanet Journal of Rare Diseases, 2012
- Maternal systemic primary carnitine deficiency uncovered by newborn screening: Clinical, biochemical, and molecular aspectsGenetics in Medicine, 2010
- Riboflavin-responsive lipid-storage myopathy caused by ETFDH gene mutationsJournal of Neurology, Neurosurgery & Psychiatry, 2009
- ETFDH mutations, CoQ10 levels, and respiratory chain activities in patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiencyNeuromuscular Disorders, 2009
- ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiencyBrain, 2007
- Expanded newborn screening identifies maternal primary carnitine deficiencyMolecular Genetics and Metabolism, 2007
- NovelOCTN2mutations: No genotype–phenotype correlations: Early carnitine therapy prevents cardiomyopathyAmerican Journal of Medical Genetics, 2002
- Evidence for Linkage of Human Primary Systemic Carnitine Deficiency with D5S436: A Novel Gene Locus on Chromosome 5qThe American Journal of Human Genetics, 1998
- Familial Systemic Carnitine DeficiencyArchives of Neurology, 1984